Related Experiment Video
Updated: Jul 5, 2026
14:23
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Mutation and control of the human immunodeficiency virus
1Department of Mechanical and Aerospace Engineering, Princeton University Princeton, P.O. Box CN5263, Princeton, NJ 08544-5263, USA. stengel@princeton.edu
Mathematical Biosciences
|April 29, 2008
Summary
Human immunodeficiency virus (HIV) therapies can control viral load but not cure infection. Optimal treatment effectiveness against drug-resistant HIV strains depends on mutant strain fitness.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Human immunodeficiency virus (HIV) infection is characterized by high viral turnover and mutation rates.
- Current anti-HIV therapies aim to minimize viral load and restore adaptive immunity but do not achieve a cure.
- The rapid evolution of drug-resistant HIV strains poses a significant challenge to effective treatment.
Purpose of the Study:
- To examine the dynamics of HIV infection and the efficacy of various therapeutic strategies.
- To investigate virtual therapies for wild-type HIV infections.
- To determine the factors influencing the containment of drug-resistant HIV strains.
Main Methods:
- Mathematical modeling of HIV infection dynamics.
- Simulation of virtual therapies for wild-type HIV.
- Analysis of the impact of viral mutation rates on treatment outcomes.
- Assessment of the role of relative fitness in the success of anti-HIV therapies.
Main Results:
- Virtual therapies can effectively manage wild-type HIV, keeping the infection in remission.
- HIV infection cannot be eradicated, necessitating continuous treatment.
- Drug-resistant HIV strains emerge rapidly due to high viral mutation rates.
- The success of optimal therapy in controlling drug-resistant strains is contingent upon the relative fitness of these mutant strains.
Conclusions:
- While current therapies can manage HIV, a cure remains elusive.
- Controlling drug-resistant HIV requires understanding and accounting for the fitness of emergent mutant strains.
- Future therapeutic strategies must consider viral evolution and fitness to ensure long-term treatment efficacy.
Related Concept Videos
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...